The UGDP Controversy: thirty-four years of contentious ambiguity laid to rest

Article Properties
Abstract
Cite
Schwartz, Theodore B, and Curtis L Meinert. “The UGDP Controversy: Thirty-Four Years of Contentious Ambiguity Laid to Rest”. Perspectives in Biology and Medicine, vol. 47, no. 4, 2004, pp. 564-7, https://doi.org/10.1353/pbm.2004.0071.
Schwartz, T. B., & Meinert, C. L. (2004). The UGDP Controversy: thirty-four years of contentious ambiguity laid to rest. Perspectives in Biology and Medicine, 47(4), 564-574. https://doi.org/10.1353/pbm.2004.0071
Schwartz TB, Meinert CL. The UGDP Controversy: thirty-four years of contentious ambiguity laid to rest. Perspectives in Biology and Medicine. 2004;47(4):564-7.
Citations
Title Journal Journal Categories Citations Publication Date
KATP channel mutations in congenital hyperinsulinism: Progress and challenges towards mechanism-based therapies

Frontiers in Endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Medicine (General)
2 2023
Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes

Diabetes Care
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases
  • Medicine: Medicine (General)
6 2022
Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas Diabetes Therapy
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Medicine (General)
4 2021
Management of Hyperglycemia in Older Adults with Type 2 Diabetes Drugs & Aging
  • Medicine: Internal medicine: Special situations and conditions: Geriatrics
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Public aspects of medicine: Toxicology. Poisons
4 2021
Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells European Journal of Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
19 2021
Citations Analysis
The category Medicine: Medicine (General) 28 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Review: Sulphonylureas and the rise and fall of beta-cell function and was published in 2005. The most recent citation comes from a 2023 study titled KATP channel mutations in congenital hyperinsulinism: Progress and challenges towards mechanism-based therapies. This article reached its peak citation in 2021, with 5 citations. It has been cited in 39 different journals, 15% of which are open access. Among related journals, the Diabetes Care cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year